The Melanoma Nursing Initiative – Home › Forums › Immunotherapy › Dosing and administration › Infusion times › Reply To: Infusion times
March 11, 2018 at 1:09 pm
#4739
NEW DOSING OF OPDIVO APPROVED 3/6/18
Opdivo (nivolumab) PI was updated for melanoma to reflect
UNRESECTABLE OR METASTATIC:
-Opdivo 240mg q 2 weeks or 480mg q 4 weeks
– Yervoy+ Opdivo 1mg/kg q 3 weeks x 4 infusions, followed by either 240mg q 2w or 480mg q 4w- maintenance
ADJUVANT:
-240mg q 2 w or 480mg q 4
INFUSION TIMES:
all are approved for Opdivo over 30min